{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T13:44:24Z","timestamp":1774791864169,"version":"3.50.1"},"reference-count":45,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.diagmicrobio.2021.115423","type":"journal-article","created":{"date-parts":[[2021,5,11]],"date-time":"2021-05-11T04:20:30Z","timestamp":1620706830000},"page":"115423","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Molecular characterization of decreased susceptibility to ceftriaxone and genotyping of Neisseria gonorrheae isolates in New Delhi, India"],"prefix":"10.1016","volume":"101","author":[{"given":"Neeraj","family":"Mahajan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seema","family":"Sood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bimal Kumar","family":"Das","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arti","family":"Kapil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vishnubhatla","family":"Sreenivas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hemanata Kumar","family":"Kar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vinod Kumar","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.diagmicrobio.2021.115423_bib0001","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1128\/AAC.00788-10","article-title":"Molecular analysis of antimicrobial resistance mechanisms in Neisseria gonorrhoeae isolates from Ontario, Canada","volume":"55","author":"Allen","year":"2011","journal-title":"Antimicrob Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2021.115423_bib0002","unstructured":"Bell SM, Pham JN, Carter IW, Hanrahan JK. Antibiotic susceptibility testing by the CDS method. A manual for medicine and veterinary laboratories. 2011, p. 45-49. [1st July 2016]. Available http:\/\/cdstest.net."},{"key":"10.1016\/j.diagmicrobio.2021.115423_bib0003","unstructured":"Bell SM, Pham JN, Rafferty DL, Allerton JK. Antibiotic susceptibility testing by the CDS method. A manual for medicine and veterinary laboratories. 2016, p. 55-62. [18th November 2020]. Availablehttp:\/\/cdstest.net\/wordpress\/wp-content\/uploads\/Antibiotic-Susceptibility-Testing-by-the-CDS-Method-8th-Edition.pdf."},{"key":"10.1016\/j.diagmicrobio.2021.115423_bib0004","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1093\/jac\/dks162","article-title":"Molecular characterization of two high-level ceftriaxone-resistant Neisseria gonorrhoeae isolates detected in Catalonia, Spain","volume":"67","author":"Camara","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2021.115423_bib0005","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.1093\/jac\/dku245","article-title":"Antimicrobial resistance, genetic resistance determinants for ceftriaxone and molecular epidemiology of Neisseria gonorrhoeae isolates in Nanjing","volume":"69","author":"Chen","year":"2014","journal-title":"China. J Antimicrob Chemother."},{"key":"10.1016\/j.diagmicrobio.2021.115423_bib0006","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1186\/s12879-015-1013-x","article-title":"Is the tide turning again for cephalosporin resistance in Neisseria gonorrhoeae in Europe? Results from the 2013 European surveillance","volume":"15","author":"Cole","year":"2015","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2021.115423_bib0007","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1128\/AAC.49.1.137-143.2005","article-title":"Emergence and spread of Neisseria gonorrhoeae clinical isolates harboring mosaic-like structure of penicillin-binding protein 2 in Central Japan","volume":"49","author":"Ito","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2021.115423_bib0008","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1134\/S0026893314060119","article-title":"The role of some individual amino acid substitutions in penicillin-binding protein (PBP2) of Neisseria gonorrhoeae in the emergence of resistance to ceftriaxone","volume":"48","author":"Kubanova","year":"2014","journal-title":"Mol Biol (Mosk)"},{"issue":"Suppl 4","key":"10.1016\/j.diagmicrobio.2021.115423_bib0009","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1136\/sextrans-2012-050906","article-title":"Gonococcal antimicrobial resistance in the Western Pacific Region","volume":"89","author":"Lahra","year":"2013","journal-title":"Sex Transm Infect"},{"key":"10.1016\/j.diagmicrobio.2021.115423_bib0010","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1056\/NEJMc1408109","article-title":"A new multidrug-resistant strain of Neisseria gonorrhoeae in Australia","volume":"371","author":"Lahra","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diagmicrobio.2021.115423_bib0011","doi-asserted-by":"crossref","first-page":"735","DOI":"10.3201\/eid2404.171873","article-title":"Cooperative recognition of internationally dissemimnated ceftriaxone-resistant Neisseria gonorrhoea strain","volume":"24","author":"Lahra","year":"2018","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2021.115423_bib0012","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1093\/jac\/dkp505","article-title":"Various penA mutations together with mtrR, porB and ponA mutations in Neisseria gonorrhoeae isolates with reduced susceptibility to cefixime or ceftriaxone","volume":"65","author":"Lee","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2021.115423_bib0013","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1093\/jac\/dkv146","article-title":"Emergence of decreased susceptibility and resistance to extended-spectrum cephalosporins in Neisseria gonorrhoeae in Korea","volume":"70","author":"Lee","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2021.115423_bib0014","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1186\/s12879-014-0622-0","article-title":"Antimicrobial susceptibility of Neisseria gonorrhoeae isolates from symptomatic men attending the Nanjing sexually transmitted diseases clinic (2011-2012): genetic characteristics of isolates with reduced sensitivity to ceftriaxone","volume":"14","author":"Li","year":"2014","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2021.115423_bib0015","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1128\/AAC.01604-06","article-title":"Neisseria gonorrhoeae isolates with reduced susceptibility to cefixime and ceftriaxone: association with genetic polymorphisms in penA, mtrR, porB1b, and ponA","volume":"51","author":"Lindberg","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2021.115423_bib0016","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1097\/OLQ.0000000000000471","article-title":"Antimicrobial Resistance and Neisseria gonorrhoeae Multiantigen Sequence Typing Profile of Neisseria gonorrhoeae in New Delhi, India","volume":"43","author":"Mahajan","year":"2016","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.diagmicrobio.2021.115423_bib0017","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1086\/383047","article-title":"Rapid sequence-based identification of gonococcal transmission clusters in a large metropolitan area","volume":"189","author":"Martin","year":"2004","journal-title":"J Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2021.115423_bib0018","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1097\/OLQ.0b013e3182401b69","article-title":"Emergence and characterization of Neisseria gonorrhoeae isolates with decreased susceptibilities to ceftriaxone and cefixime in Canada: 2001-2010","volume":"39","author":"Martin","year":"2012","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.diagmicrobio.2021.115423_bib0019","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1128\/AAC.45.9.2651-2654.2001","article-title":"Multidrug-resistant strains of Neisseria gonorrhoeae in Greece","volume":"45","author":"Mavroidi","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2021.115423_bib0020","first-page":"1","article-title":"National Guidelines on Prevention, Management and Control of Reproductive Tract Infections and Sexually Transmitted Infections","year":"2014","journal-title":"Department of AIDS Control MOHFW, Government of India"},{"key":"10.1016\/j.diagmicrobio.2021.115423_bib0021","doi-asserted-by":"crossref","first-page":"3538","DOI":"10.1128\/AAC.00325-11","article-title":"Is Neisseria gonorrhoeae initiating a future era of untreatable gonorrhea?: detailed characterization of the first strain with high-level resistance to ceftriaxone","volume":"55","author":"Ohnishi","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2021.115423_bib0022","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1128\/AAC.46.9.2811-2820.2002","article-title":"Identification and analysis of amino acid mutations in porin IB that mediate intermediate-level resistance to penicillin and tetracycline inNeisseria gonorrhoeae","volume":"46","author":"Olesky","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2021.115423_bib0023","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1471-2334-13-40","article-title":"Antimicrobial susceptibility and genetic characteristics of Neisseria gonorrhoeae isolates from Vietnam, 2011","volume":"13","author":"Olsen","year":"2013","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2021.115423_bib0024","unstructured":"Public Health England. UK case of Neisseria gonorrhoeae with high-level resistance to azithromycin and resistance to ceftriaxone acquired abroad. 2018;12(11). [18th November 2020]. Availablehttps:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/694655\/hpr1118_MDRGC.pdf."},{"key":"10.1016\/j.diagmicrobio.2021.115423_bib0025","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1128\/AAC.46.3.769-777.2002","article-title":"Mutations in ponA, the gene encoding penicillin-binding protein 1, and a novel locus, penC, are required for high-level chromosomally mediated penicillin resistance in Neisseria gonorrhoeae","volume":"46","author":"Ropp","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2021.115423_bib0026","doi-asserted-by":"crossref","first-page":"109","DOI":"10.4103\/ijmm.IJMM_16_46","article-title":"Mutation pattern in the genome of Neisseria gonorrhoeae and its association with multidrug-resistant Isolates from Delhi, India","volume":"35","author":"Sachdev","year":"2017","journal-title":"Indian J Med Microbiol"},{"key":"10.1016\/j.diagmicrobio.2021.115423_bib0027","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1007\/s10096-016-2696-7","article-title":"Neisseria gonorrhoeae antimicrobial susceptibility in Barcelona: penA, ponA, mtrR, and porB mutations and NG-MAST sequence types associated with decreased susceptibility to cephalosporins","volume":"35","author":"Serra-Pladevall","year":"2016","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2021.115423_bib0028","first-page":"6","article-title":"Emergence of decreased susceptibility to extended-spectrum cephalosporins in Neisseria gonorrhoeae in India","volume":"26","author":"Sood","year":"2013","journal-title":"Natl Med J India"},{"issue":"Suppl 1","key":"10.1016\/j.diagmicrobio.2021.115423_bib0029","doi-asserted-by":"crossref","first-page":"64","DOI":"10.4103\/ijmr.IJMR_730_15","article-title":"Exploring quinolone resistance-determining region in Neisseria gonorrhoeae isolates from across India","volume":"146","author":"Sood","year":"2017","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.diagmicrobio.2021.115423_bib0030","doi-asserted-by":"crossref","first-page":"467","DOI":"10.7883\/yoken.JJID.2009.467","article-title":"Prevalence of Chlamydia trachomatis and Neisseria gonorrhoeae in HIV-seropositive patients and gonococcal antimicrobial susceptibility: an update in Thailand","volume":"62","author":"Srifeungfung","year":"2009","journal-title":"Jpn J Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2021.115423_bib0031","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.15585\/mmwr.mm6950a6","article-title":"Update to CDC's Treatment Guidelines for Gonococcal Infection","volume":"69","author":"St. Cyr","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.diagmicrobio.2021.115423_bib0032","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1186\/1471-2334-10-323","article-title":"Predominant porB1A and porB1B genotypes and correlation of gene mutations with drug resistance in Neisseria gonorrhoeae isolates in Eastern China","volume":"10","author":"Sun","year":"2010","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2021.115423_bib0033","doi-asserted-by":"crossref","first-page":"3638","DOI":"10.1128\/AAC.00626-06","article-title":"Amino acid substitutions in mosaic penicillin-binding protein 2 associated with reduced susceptibility to cefixime in clinical isolates of Neisseria gonorrhoeae","volume":"50","author":"Takahata","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2021.115423_bib0034","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1093\/jac\/dkt543","article-title":"Unique combined penA\/mtrR\/porB mutations and NG-MAST strain types associated with ceftriaxone and cefixime MIC increases in a 'susceptible' Neisseria gonorrhoeae population","volume":"69","author":"Thakur","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2021.115423_bib0035","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1093\/jac\/dkp098","article-title":"Phenotypic and genetic characterization of the 2008 WHO Neisseria gonorrhoeae reference strain panel intended for global quality assurance and quality control of gonococcal antimicrobial resistance surveillance for public health purposes","volume":"63","author":"Unemo","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2021.115423_bib0036","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1128\/AAC.05760-11","article-title":"High-level cefixime- and ceftriaxone-resistant Neisseria gonorrhoeae in France: novel penA mosaic allele in a successful international clone causes treatment failure","volume":"56","author":"Unemo","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2021.115423_bib0037","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1128\/CMR.00010-14","article-title":"Antimicrobial resistance in Neisseria gonorrhoeae in the 21st century: past, evolution, and future","volume":"27","author":"Unemo","year":"2014","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.diagmicrobio.2021.115423_bib0038","doi-asserted-by":"crossref","first-page":"5619","DOI":"10.1128\/JB.184.20.5619-5624.2002","article-title":"Overexpression of the MtrC-MtrD-MtrE efflux pump due to an mtrR mutation is required for chromosomally mediated penicillin resistance in Neisseria gonorrhoeae","volume":"184","author":"Veal","year":"2002","journal-title":"J Bacteriol"},{"key":"10.1016\/j.diagmicrobio.2021.115423_bib0039","doi-asserted-by":"crossref","first-page":"3111","DOI":"10.1128\/AAC.00306-07","article-title":"Diversity of penA alterations and subtypes in Neisseria gonorrhoeae strains from Sydney, Australia, that are less susceptible to ceftriaxone","volume":"51","author":"Whiley","year":"2007","journal-title":"AntimicrobAgents Chemother"},{"key":"10.1016\/j.diagmicrobio.2021.115423_bib0040","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1128\/AAC.01307-06","article-title":"Further questions regarding the role of mosaic penA sequences in conferring reduced susceptibility to ceftriaxone in Neisseria gonorrhoeae","volume":"51","author":"Whiley","year":"2007","journal-title":"AntimicrobAgents Chemother"},{"key":"10.1016\/j.diagmicrobio.2021.115423_bib0041","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1093\/jac\/dkq187","article-title":"Reduced susceptibility to ceftriaxone in Neisseria gonorrhoeae is associated with mutations G542S, P551S and P551L in the gonococcal penicillin-binding protein 2","volume":"65","author":"Whiley","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2021.115423_bib0042","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S1473-3099(18)30340-2","article-title":"Genetic characterisation of Neisseria gonorrhoeae resistant to both ceftriaxone and azithromycin","volume":"18","author":"Whiley","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2021.115423_bib0043","series-title":"Regional Office for South-East Asia. Laboratory diagnosis of gonorrhea","first-page":"45","year":"1999"},{"key":"10.1016\/j.diagmicrobio.2021.115423_bib0044","series-title":"WHO guidelines for the treatment of Neisseria gonorrhoeae","first-page":"17","year":"1999"},{"key":"10.1016\/j.diagmicrobio.2021.115423_bib0045","doi-asserted-by":"crossref","first-page":"3744","DOI":"10.1128\/AAC.00304-09","article-title":"Genetics of chromosomally mediated intermediate resistance to ceftriaxone and cefixime in Neisseria gonorrhoeae","volume":"53","author":"Zhao","year":"2009","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889321001164?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889321001164?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T09:56:14Z","timestamp":1760003774000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0732889321001164"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["S0732889321001164"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2021.115423","relation":{},"ISSN":["0732-8893"],"issn-type":[{"value":"0732-8893","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular characterization of decreased susceptibility to ceftriaxone and genotyping of Neisseria gonorrheae isolates in New Delhi, India","name":"articletitle","label":"Article Title"},{"value":"Diagnostic Microbiology and Infectious Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2021.115423","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115423"}}